Skip to content

PTHS PTHS Non-Cash Lease Expense

Non-Cash Lease Expense at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$285.18K0.0%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$23K+9.5%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$118K
Theravance Biopharma logo
Theravance BiopharmaTBPH
$1.06M+9.3%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$16.84K

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's non-cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's non-cash lease expense?
PTHS (PTHS) reported non-cash lease expense of $70K in Q1 2026.
What does non-cash lease expense mean?
Non-cash portion of operating lease cost — the difference between straight-line lease expense and actual cash rent payments.